Skip to main content
BIO CEO & Investor Conference Logo

February 10-11, 2025・New York, NY

BIO CEO & Investor Conference Logo

February 10-11, 2025・New York, NY

2024 Company Presentation Schedule

blue gradient

Company Presentations are sponsored by: 

bioharvest sciences

Loading
Search Filters
  • Therapeutic Focus
  • Date
  • Starttime
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
  • Date
    • Monday, February 26, 2024
  • Starttime
    • 1:00 PM
    • 1:15 PM
    • 1:30 PM
    • 1:45 PM
    • 2:00 PM
    • 2:15 PM
    • 2:30 PM
    • 2:45 PM
    • 3:00 PM
    • 3:15 PM
    • 3:30 PM
    • 3:45 PM
    • 4:00 PM
    • 4:15 PM
    • 4:30 PM
    • 4:45 PM
1:00 PM
  1. Protalix Biotherapeuticss
    Plymouth
    15 mins
    Mr. Dror Bashan, President & CEO - Protalix Biotheraeutics
  2. BioInvent International
    Uris
    15 mins
    Mr. Martin Welschof, CEO - BioInvent International
  3. IN8bio
    Royale
    15 mins
    Mr. William Ho, President & CEO - IN8bio
1:15 PM
  1. Cognigenics
    Royale
    15 mins
    Mr. Tom Lytle, Vice President - Cognigenics
  2. Tactical Therapeutics, Inc
    Uris
    15 mins
    Dr. Rashida Karmali, Chief Executive Officer & President - Tactical Therapeutics,Inc
  3. Sernova
    Plymouth
    15 mins
    Cynthia Pussinen, Chief Executive Officer - Sernova Corp.
1:30 PM
  1. Leapfrog Bio
    Uris
    15 mins
    Mr. Greg Vontz, CEO - Leapfrog Bio
  2. Genprex, Inc.
    Plymouth
    15 mins
    Mr. Ryan Confer, Chief Financial Officer - Genprex, Inc.
  3. Tonix Pharmaceuticals
    Royale
    15 mins
    Dr. Seth Lederman, Chief Executive Officer - TONIX Pharmaceuticals
1:45 PM
  1. ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
    Uris
    15 mins
    Dr. Wenzhi Tian, Founder, Chairman & CEO - ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
  2. Ocugen
    Plymouth
    15 mins
    Dr. Shankar Musunuri, Chairman, CEO and Co-Founder - Ocugen, Inc.
  3. Allyx Therapeutics
    Royale
    15 mins
    Timothy Siegert, COO - Allyx Therapeutics
2:00 PM
  1. Carina Biotech Limited
    Uris
    15 mins
    Dr. Deborah Rathjen, CEO - Carina Biotech
  2. CervoMed, Inc.
    Royale
    15 mins
    Dr. John Alam, CEO - CervoMed Inc.
  3. Cell BioEngines, Inc
    Plymouth
    15 mins
    Dr. Ajay Vishwakarma, Founder and CEO - Cell BioEngines, Inc
2:15 PM
  1. Immunis Inc.
    Plymouth
    15 mins
    Dr. Hans Keirstead, Chairman of the Board - Immunis, Inc.
  2. Lyndra Therapeutics
    Royale
    15 mins
    Jessica Ballinger, President & CEO - Lyndra Therapeutics
  3. Avstera Therapeutics Corp.
    Uris
    15 mins
    Karthik Musunuri, CEO & Co-Founder - Avstera Therapeutics Corp.
2:30 PM
  1. Cyclacel Pharmaceuticals, Inc.
    Uris
    15 mins
    Mr. Spiro Rombotis, President and CEO - Cyclacel Pharmaceuticals, Inc.
  2. SIRPant Immunotherapeutics, Inc.
    Plymouth
    15 mins
    Mr. Robert Towarnicki, President & CEO - SIRPant Immunotherapeutics Inc.
  3. NRx Pharmaceuticals
    Royale
    15 mins
    Jonathan Javitt, Chairman and Chief Scientist - NRx Pharma
2:45 PM
  1. Resolution Therapeutics
    Plymouth
    15 mins
    Dr. Amir Hefni, CEO - Resolution Therapeutics
  2. Chimeric Therapeutics
    Uris
    15 mins
    Ms. Jennifer Chow, CEO and Managing Director - Chimeric Therapeutics
  3. Reviva Pharmaceuticals
    Royale
    15 mins
    Dr. Laxminarayan Bhat, CEO - Reviva Pharmaceuticals Inc
3:00 PM
  1. Ziphius
    Royale
    15 mins
    Mr. Chris Cardon, CEO - Ziphius
  2. Rejuvenate Biomed
    Uris
    15 mins
    Dr. Ann BELIEN, Founder & CEO - Rejuvenate Biomed
3:15 PM
  1. SAB Biotherapeutics, Inc.
    Royale
    15 mins
    Samuel Reich, Chairman and CEO - SAB Biotherapeutics
  2. Genesis Healthcare Co.
    Uris
    15 mins
    Mr. Michel Mommejat, Chief Innovation Officer - Genesis Healthcare
  3. Coastar Therapeutics Inc.
    Plymouth
    15 mins
    Eddie Chung, CEO - Coastar Therapeutics Inc.
3:30 PM
  1. Inimmune
    Royale
    15 mins
    Dr. Alan Joslyn, Chief Executive Officer - Inimmune Inc.
  2. Papillon Therapeutics, Inc.
    Plymouth
    15 mins
    Carter Cliff, CEO - Papillon Therapeutics, Inc.
  3. Vincogen Corporation
    Uris
    15 mins
    Mr. Alexander Lai, Chief Technology Officer (CTO) - Vincogen Corporation
3:45 PM
  1. Revelation Biosciences Inc.
    Royale
    15 mins
    Mr. James Rolke, CEO - Revelation Biosciences Inc
  2. Portal Instruments, Inc.
    Uris
    15 mins
    Dr. Patrick Anquetil, CEO - Portal Instruments
  3. Garuda Therapeutics, Inc.
    Plymouth
    15 mins
    Dr. Dhvanit Shah, President and CEO - Garuda Therapeutics
4:00 PM
  1. Sapience Therapeutics
    Uris
    15 mins
    Barry Kappel, President, CEO & Founder - Sapience Therapeutics
  2. EG 427
    Plymouth
    15 mins
    Mr. Don Haut, Chief Business Officer - EG 427
  3. Diamyd Medical
    Royale
    15 mins
    Dr. Christoph Nowak, Chief Medical and Business Officer - Diamyd Medical
4:15 PM
  1. GeoVax Labs, Inc.
    Royale
    15 mins
    David Dodd, Chairman & CEO - GeoVax Labs, Inc.
  2. Alligator Bioscience
    Uris
    15 mins
    Dr. Soren BREGENHOLT, CEO - Alligator Bioscience
  3. Navega Therapeutics
    Plymouth
    15 mins
    Ana Moreno, CEO and Founder - Navega Therapeutics
4:30 PM
  1. Uvax Bio, LLC
    Royale
    15 mins
    Mr. Kevin O'Neill, Sr. Vice President - Uvax Bio, LLC
  2. Sustained Therapeutics
    Plymouth
    15 mins
    Mr. William Annett, CEO - Sustained Theraeputics
  3. Innova Therapeutics
    Uris
    15 mins
    Dr. Robert ryan, CEO - Innova Therapeutics
4:45 PM
  1. Merlin Biotech, Inc.
    Uris
    15 mins
    Dr. Randall Hyer, CEO - Merlin Biotech, Inc.
  2. Gentas Biotechnology
    Royale
    15 mins
    Jeffrey Carper, Managing Partner - Gentas Biotechnology
  3. Nanoscope Therapeutics
    Plymouth
    15 mins
    Sulagna Bhattacharya, CEO - Nanoscope Therapeutics
Testimonials
  • It's the kind of meeting where biotech newsmakers can have productive dialogs with investors and other key players.
    Luke Timmerman
    The Timmerman Report
  • It's the caliber of attendees - biopharma companies on the verge of their next big step and investors looking for smart opportunities - that make BIO CEO & Investor Conference vital to the industry.
    Anna Kazanchyan, MD
    Founder & CEO, Saghmos Therapeutics
  • The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem.
    Philip Ross, MD
    Global Chairman, J.P. Morgan Healthcare Investment Banking
  • The BIO CEO & Investor Conference provides timely and relevant content on the issues driving the business of biotech, along with an invaluable platform for networking and partnering.
    Chris Garabedian
    Chairman and CEO, Xontogeny and Portfolio Manager, PXV Fund

Double Helix

Loading

 

Supporting Bank Sponsor

Loading

 

Premier Sponsors

Loading

Conference Sponsors

Loading

 

Media Partner

Loading

 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP

Search